BlackRock Fund Advisors - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 149 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$98,651,000
+8.0%
6,452,010
+12.2%
0.02%
-5.3%
Q3 2016$91,311,000
+26.8%
5,750,071
+4.4%
0.02%
+18.8%
Q2 2016$72,002,000
+18.9%
5,506,855
-0.5%
0.02%
+14.3%
Q1 2016$60,545,000
-6.3%
5,534,320
-0.7%
0.01%
-6.7%
Q4 2015$64,621,000
+5.7%
5,575,596
-4.9%
0.02%
-6.2%
Q3 2015$61,110,000
-13.9%
5,864,667
-0.4%
0.02%
-5.9%
Q2 2015$70,994,000
-21.7%
5,886,692
+3.9%
0.02%
-22.7%
Q1 2015$90,666,000
+10.9%
5,666,614
+6.2%
0.02%
+10.0%
Q4 2014$81,761,000
+32.1%
5,336,875
+11.7%
0.02%
+17.6%
Q3 2014$61,916,000
-14.4%
4,779,331
+1.2%
0.02%
-15.0%
Q2 2014$72,373,000
+18.4%
4,720,980
-4.8%
0.02%
+11.1%
Q1 2014$61,106,000
+32.7%
4,959,931
+25.1%
0.02%
+28.6%
Q4 2013$46,040,000
+0.6%
3,965,586
+2.6%
0.01%
-6.7%
Q3 2013$45,756,000
+35.1%
3,864,496
+13.3%
0.02%
+25.0%
Q2 2013$33,870,0003,410,8370.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders